<qa>  What is the effect of TAK-385 40 mg administered orally once daily for 12 weeksThis is a phase 3, multicenter, randomized, double-blind, parallel-group study to evaluate the efficacy of TAK-385 40 mg administered orally once daily for 12 weeks compared with placebo in participants having pain symptoms associated with uterine fibroids. 